Johnson & Johnson
Page 3 of 18
By Kristine GillSeptember 16, 2022
FinanceThe world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By Paige McGlauflinAugust 15, 2022
By Riley Griffin, Jef Feeley and BloombergAugust 11, 2022
FinanceMusk claims S&P ‘lost their integrity’ after Tesla gets booted from sustainability index while Exxon is included
By Christiaan HetznerMay 18, 2022
HealthFDA restricts Johnson & Johnson’s COVID-19 vaccine to people 18 and older due to blood clot risk
By Matthew Perrone, Lauran Neergaard and The Associated PressMay 5, 2022
HealthThe most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By Sy Mukherjee and IDEA PharmaApril 20, 2022
HealthThe weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By Andrew MarquardtMarch 15, 2022
LeadershipApple, Walt Disney, and UnitedHealth have this in common: Their business rivals give them ultra-high performance scores
By Matthew Heimer and Scott DeCarloFebruary 2, 2022
By Erika Fry and Nicolas RappJanuary 5, 2022
HealthA Johnson & Johnson booster reduces Omicron hospitalizations by up to 85%, says a new South African study
By Michelle Fay Cortez and BloombergDecember 30, 2021
HealthModerna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021
HealthJ&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By BloombergDecember 17, 2021
By Bernhard WarnerDecember 17, 2021
Most Popular
